February 8, 2021
ARDEN HILLS, Minn. , Feb. 08, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that Ellen Scipta has been Read More
November 9, 2020
ARDEN HILLS, Minn. , Nov. 09, 2020 (GLOBE NEWSWIRE) -- Intri c on Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced financial results for its third Read More
November 4, 2020
ARDEN HILLS, Minn. , Nov. 04, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer, manufacturer and distributor of body-worn devices, today announced that Scott Longval , IntriCon’s President and Chief Executive Officer will present at the upcoming Virtual 2020 Read More
August 10, 2020
ARDEN HILLS, Minn. , Aug. 10, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced financial results for its second Read More
June 25, 2020
J. Scott Longval to Succeed Mark Gorder as President and CEO, Effective October 1, 2020 ARDEN HILLS, Minn. , June 25, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today Read More
May 19, 2020
ARDEN HILLS, Minn. , May 19, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced financial results for its first quarter ended March 31, 2020 . Read More
May 19, 2020
Synergistic joint development and manufacturing capability expands market opportunity in surgical navigation Provides immediate access to technology platform serving new high growth medical end-markets with complex interventional catheters   Accretive transaction delivers long-term revenue growth Read More